Logo
  • About
  • Contact
  • (888) 441-8033

Eliyan Sets New Standard for Chiplet Interconnect Performance with Latest PHY Delivering Data Rate of 64Gbps on 3nm Process Using Standard Packaging

SANTA CLARA, Calif. – February 5, 2024 – Eliyan Corporation, credited for the invention of the semiconductor industry’s highest-performance and most efficient chiplet interconnect, today announced the successful tape out of the industry’s highest performing PHY solution for mu...

View full release

BOMA NEW YORK ANNOUNCES NEW OFFICERS WITH PAT DOLAN OF THE DURST ORGANIZATION AS ITS NEW CHAIR

NEW YORK, NY (February 5, 2024) BOMA New York, the City’s most influential commercial real estate trade organization, is proud to announce that Patrick J. Dolan, RPA, Senior Property Manager at The Durst Organization and head of operations at One World Trade Center is the new ...

View full release

SERI ACQUIRES THE E-REUSE CONFERENCE; REBRANDS AS THE ELECTRONICS SUSTAINABILITY SUMMIT FOR 2024 LAUNCH

SERI, a 501(c)(3) nonprofit electronics sustainability organization based in the United States announced today that it has acquired the E-Reuse Conference from E-Reuse Services, and beginning with the fall 2024 event, will rebrand the conference to launch the new Electronics S...

View full release

UGI To Continue System Upgrades Along Portions of Penn Avenue in West Reading Borough

UGI Utilities, Inc. will begin the next phase of a natural gas main replacement project the week of March 4 that will impact the Borough of West Reading. The project will take place on the 500, 600, 700, and 800 blocks of Penn Avenue, also known as 422 Business. Work is schedu...

View full release

InFlectis BioScience Completes Enrollment of its Phase 2 trial of IFB-088 for the Treatment of Amyotrophic Lateral Sclerosis; Anticipates Initial Results Later this Year

Nantes, France, January 31, 2024 -- InFlectis BioScience, a pioneer in developing first-in-class therapies for neuromuscular diseases, announced that it has completed enrollment in its Phase 2 clinical trial of IFB-088 ((INN: icerguastat), a novel investigational treatment of ...

View full release

Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (NASDAQ: ARLP) 2023 Q4

DALLAS, TX -- January 30th, 2024 -- Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P.  ARLP Releases Full Year 2023 and 4Q23 Earnings ARLP reported solid 4Q23 results that capped a record year, des...

View full release

A-Mark Foundation Launches New Resource Presenting Unbiased Facts on the Israeli-Palestinian Conflict

January 26, 2024 — Los Angeles, Calif. — A-Mark Foundation, a nonprofit organization dedicated to providing unbiased information on critical issues, launched a new resource aimed at answering 10 common questions about the Israeli-Palestinian conflict. The initiative comes in r...

View full release

Location Change, Speaker Update for the 2024 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit

SALT LAKE CITY -– January 22, 2024 – BioUtah, Utah’s trade association dedicated to the life sciences community, in partnership with the University of Utah’s Technology Licensing Office, today announced a venue change and speaker update for the 2024 Entrepreneur and Investor L...

View full release

RIVERDALE MILLS SEEKS LEGAL COSTS DEFENDING UNFOUNDED OSHA CHARGES

NORTHBRIDGE, MA -- After the U.S. Supreme Court late last year declined to hear a case involving alleged workplace violations brought by the Occupational Health and Safety Administration that bears directly on the currently contested authority of federal regulators, Riverdale ...

View full release

Pacylex Pharmaceuticals Reports Phase 1 Safety and Efficacy Results for Zelenirstat in Colorectal and other Cancers

Edmonton, Alberta, Canada January. 16, 2023. Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company focused on the development of a new class of targeted therapies, N-myristoyltransferase inhibitors (NMTi) for the treatment of hematologic and solid t...

View full release
  • « First
  • ‹ Prev
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy